// App-Quantinova.ai

84 : The efficacy and cost savings of switching to a single 1g infusion protocol of biosimilar rituximab for rheumatoid arthritis

Researchers

Presenter

  • Yu Lun Sung

Principal Investigators

  • Cristina Pijoan-Moratalla

  • Martin A Lee

Medical Centers

  • Medical School, Newcastle, Newcastle upon Tyne, UNITED KINGDOM

  • Rheumatology Department, Freeman Hospital, Newcastle-Upon-Tyne, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

  • HWA-486

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved